Fingerprint
Dive into the research topics of 'A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors
Filippo de Braud, S. Cascinu, G. Spitaleri, K. Pilz, L. Clementi, D. Liu, P. Sikken, T. De Pas
Research output: Contribution to journal › Article › peer-review